Hai V Tran
Examiner (ID: 9064, Phone: (571)270-7650 , Office: P/2845 )
Most Active Art Unit | 2845 |
Art Unit(s) | 2611, 2845, 2426, 4100, 2711, 2623, 2423, 2491, 2821 |
Total Applications | 1291 |
Issued Applications | 923 |
Pending Applications | 111 |
Abandoned Applications | 257 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 17776556
[patent_doc_number] => 20220242905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => MODIFIED PEPTIDES AND THEIR USE
[patent_app_type] => utility
[patent_app_number] => 17/278558
[patent_app_country] => US
[patent_app_date] => 2019-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12655
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17278558
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/278558 | MODIFIED PEPTIDES AND THEIR USE | Sep 25, 2019 | Abandoned |
Array
(
[id] => 17578783
[patent_doc_number] => 20220135638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => GIP RECEPTOR AGONIST PEPTIDE COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/279266
[patent_app_country] => US
[patent_app_date] => 2019-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35328
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17279266
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/279266 | GIP RECEPTOR AGONIST PEPTIDE COMPOUNDS AND USES THEREOF | Sep 23, 2019 | Pending |
Array
(
[id] => 15342647
[patent_doc_number] => 20200009215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF OPIOID INDUCED DYSFUNCTIONS
[patent_app_type] => utility
[patent_app_number] => 16/577880
[patent_app_country] => US
[patent_app_date] => 2019-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23908
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16577880
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/577880 | AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF OPIOID INDUCED DYSFUNCTIONS | Sep 19, 2019 | Abandoned |
Array
(
[id] => 15454429
[patent_doc_number] => 20200040039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-06
[patent_title] => PEPTIDE COMPOUND AND METHOD FOR PRODUCING SAME, COMPOSITION FOR SCREENING USE, AND METHOD FOR SELECTING PEPTIDE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 16/577517
[patent_app_country] => US
[patent_app_date] => 2019-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47815
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 183
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16577517
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/577517 | Peptide compound and method for producing same, composition for screening use, and method for selecting peptide compound | Sep 19, 2019 | Issued |
Array
(
[id] => 18101251
[patent_doc_number] => 11541122
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-03
[patent_title] => Glucose sensitive insulins and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/274802
[patent_app_country] => US
[patent_app_date] => 2019-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 18163
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17274802
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/274802 | Glucose sensitive insulins and uses thereof | Sep 17, 2019 | Issued |
Array
(
[id] => 15324137
[patent_doc_number] => 20200002398
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => De Novo Design of Potent and Selective Interleukin Mimetics
[patent_app_type] => utility
[patent_app_number] => 16/572038
[patent_app_country] => US
[patent_app_date] => 2019-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32010
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16572038
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/572038 | De novo design of potent and selective interleukin mimetics | Sep 15, 2019 | Issued |
Array
(
[id] => 15342677
[patent_doc_number] => 20200009230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => COMPOSITION AND METHODS FOR TREATING ISCHEMIC WOUNDS AND INFLAMMATORY CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 16/571383
[patent_app_country] => US
[patent_app_date] => 2019-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8214
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16571383
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/571383 | Composition and methods for treating ischemic wounds and inflammatory conditions | Sep 15, 2019 | Issued |
Array
(
[id] => 15553497
[patent_doc_number] => 20200061160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => USES OF PTHrP ANALOGUE IN REDUCING FRACTURE RISK
[patent_app_type] => utility
[patent_app_number] => 16/566499
[patent_app_country] => US
[patent_app_date] => 2019-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22548
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16566499
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/566499 | USES OF PTHrP ANALOGUE IN REDUCING FRACTURE RISK | Sep 9, 2019 | Abandoned |
Array
(
[id] => 15454427
[patent_doc_number] => 20200040038
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-06
[patent_title] => Process of Preparing Guanylate Cyclase C Agonists
[patent_app_type] => utility
[patent_app_number] => 16/546707
[patent_app_country] => US
[patent_app_date] => 2019-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28855
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -48
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16546707
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/546707 | Process of Preparing Guanylate Cyclase C Agonists | Aug 20, 2019 | Abandoned |
Array
(
[id] => 17035151
[patent_doc_number] => 20210252109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => USE OF GHRP-6 AS LATE CARDIOPROTECTIVE AND CARDIAC RESTORATION MEDICAMENT
[patent_app_type] => utility
[patent_app_number] => 17/269874
[patent_app_country] => US
[patent_app_date] => 2019-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6970
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17269874
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/269874 | Use of GHRP-6 as late cardioprotective and cardiac restoration medicament | Aug 18, 2019 | Issued |
Array
(
[id] => 16086677
[patent_doc_number] => 20200197325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => METHODS INVOLVING DOWNREGULATING APOBEC3B
[patent_app_type] => utility
[patent_app_number] => 16/531475
[patent_app_country] => US
[patent_app_date] => 2019-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9374
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16531475
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/531475 | METHODS INVOLVING DOWNREGULATING APOBEC3B | Aug 4, 2019 | Abandoned |
Array
(
[id] => 17035146
[patent_doc_number] => 20210252104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => ANTIBACTERIAL PEPTIDE MONOMERS AND COMBINATIONS FOR CO-THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/259301
[patent_app_country] => US
[patent_app_date] => 2019-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14393
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17259301
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/259301 | ANTIBACTERIAL PEPTIDE MONOMERS AND COMBINATIONS FOR CO-THERAPY | Jul 11, 2019 | Pending |
Array
(
[id] => 16383217
[patent_doc_number] => 10808039
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-20
[patent_title] => Monomethylvaline compounds capable of conjugation to ligands
[patent_app_type] => utility
[patent_app_number] => 16/507839
[patent_app_country] => US
[patent_app_date] => 2019-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 43
[patent_no_of_words] => 69869
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16507839
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/507839 | Monomethylvaline compounds capable of conjugation to ligands | Jul 9, 2019 | Issued |
Array
(
[id] => 17913228
[patent_doc_number] => 20220315623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => Cyclic Peptide Compound Simulating Natural Product Structure, And Method For Preparation Thereof
[patent_app_type] => utility
[patent_app_number] => 17/610783
[patent_app_country] => US
[patent_app_date] => 2019-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11506
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17610783
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/610783 | Cyclic Peptide Compound Simulating Natural Product Structure, And Method For Preparation Thereof | Jun 20, 2019 | Pending |
Array
(
[id] => 16954919
[patent_doc_number] => 11058747
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-13
[patent_title] => Reconstituted high density lipoprotein formulation and production method thereof
[patent_app_type] => utility
[patent_app_number] => 16/445937
[patent_app_country] => US
[patent_app_date] => 2019-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9781
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16445937
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/445937 | Reconstituted high density lipoprotein formulation and production method thereof | Jun 18, 2019 | Issued |
Array
(
[id] => 16992239
[patent_doc_number] => 20210230659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => Leader Sequence for Higher Expression of Recombinant Proteins
[patent_app_type] => utility
[patent_app_number] => 17/053596
[patent_app_country] => US
[patent_app_date] => 2019-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8393
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17053596
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/053596 | Leader Sequence for Higher Expression of Recombinant Proteins | Jun 17, 2019 | Pending |
Array
(
[id] => 17355404
[patent_doc_number] => 20220016200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CYSTIC FIBROSIS
[patent_app_type] => utility
[patent_app_number] => 17/312351
[patent_app_country] => US
[patent_app_date] => 2019-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7026
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17312351
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/312351 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CYSTIC FIBROSIS | Jun 13, 2019 | Pending |
Array
(
[id] => 17020919
[patent_doc_number] => 20210244790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => ENHANCEMENT OF ANTIBACTERIAL ACTIONS OF A DEPSIPEPTIDE ANTIBIOTIC USING SYNERGISTIC AMOUNTS OF BORIC ACID
[patent_app_type] => utility
[patent_app_number] => 17/251367
[patent_app_country] => US
[patent_app_date] => 2019-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11855
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17251367
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/251367 | ENHANCEMENT OF ANTIBACTERIAL ACTIONS OF A DEPSIPEPTIDE ANTIBIOTIC USING SYNERGISTIC AMOUNTS OF BORIC ACID | Jun 11, 2019 | Pending |
Array
(
[id] => 16990264
[patent_doc_number] => 20210228684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => SILK-BASED PRODUCT FORMULATIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/972021
[patent_app_country] => US
[patent_app_date] => 2019-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 132642
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16972021
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/972021 | Silk-based product formulations and methods of use | Jun 3, 2019 | Issued |
Array
(
[id] => 16913886
[patent_doc_number] => 20210186978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => COMBINATION THERAPY
[patent_app_type] => utility
[patent_app_number] => 15/734110
[patent_app_country] => US
[patent_app_date] => 2019-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17569
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15734110
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/734110 | COMBINATION THERAPY | May 30, 2019 | Pending |